- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/49 - Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
Patent holdings for IPC class C07D 239/49
Total number of patents in this class: 113
10-year publication summary
|
8
|
19
|
14
|
15
|
5
|
14
|
8
|
3
|
3
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Pharma Co., Ltd. | 636 |
15 |
| Apros Therapeutics, Inc. | 9 |
6 |
| AstraZeneca AB | 2962 |
5 |
| Dainippon Sumitomo Pharma Co., Ltd. | 210 |
5 |
| AstraZeneca UK Limited | 693 |
4 |
| The Trustees of the University of Pennsylvania | 4273 |
4 |
| FUJIFILM Corporation | 28841 |
3 |
| Board of Regents, The University of Texas System | 5641 |
3 |
| Calitor Sciences, LLC | 37 |
3 |
| Oat Agrio Co., Ltd. | 35 |
3 |
| Plexxikon Inc. | 154 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 572 |
3 |
| Tokyo University of Science Foundation | 369 |
3 |
| Acea Therapeutics, Inc. | 27 |
3 |
| Bristol-myers Squibb Company | 4861 |
2 |
| Massachusetts Institute of Technology | 9930 |
2 |
| eFFECTOR Therapeutics, Inc. | 69 |
2 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 900 |
2 |
| Minoryx Therapeutics S.L. | 47 |
2 |
| Roche Palo Alto LLC | 75 |
2 |
| Other owners | 38 |